Trending
March 17, 2025 Arch Street Capital Advisors And Artemis Real Estate Partners Acquire 2.4 Million Square Foot Industrial Portfolio In Kansas City, MSAMarch 17, 2025 CoreWeave Appoints Meg Whitman as Independent Board DirectorMarch 17, 2025 iOncologi Appoint Dr. Mona Flores and Mr. Paolo Fundarò To BoardMarch 17, 2025 The Designery Opens its First New York State Location in RochesterMarch 17, 2025 Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
March 17, 2025 Arch Street Capital Advisors And Artemis Real Estate Partners Acquire 2.4 Million Square Foot Industrial Portfolio In Kansas City, MSAMarch 17, 2025 CoreWeave Appoints Meg Whitman as Independent Board DirectorMarch 17, 2025 iOncologi Appoint Dr. Mona Flores and Mr. Paolo Fundarò To BoardMarch 17, 2025 The Designery Opens its First New York State Location in RochesterMarch 17, 2025 Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
Featured
March 17, 2025
Arch Street Capital Advisors And Artemis Real Estate Partners Acquire 2.4 Million Square Foot Industrial Portfolio In Kansas City, MSA
Arch Street Capital Advisors, a leading real estate investment firm, in partnership with Artemis Real Estate Partners,... Read more »
March 17, 2025
CoreWeave Appoints Meg Whitman as Independent Board Director
CoreWeave, the AI Hyperscaler, today announced the appointment of Meg Whitman as an independent member of the Company's... Read more »
March 17, 2025
iOncologi Appoint Dr. Mona Flores and Mr. Paolo Fundarò To Board
iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for... Read more »
